Ensuring continuous high-quality care for people with impaired cognition including dementia at the end of life
Providing care that is continuous over time for individuals is part of high-quality care, and may become more important at the end of life. We hate to explain ourselves to different health-care professionals over and over again. We recognised continuity of care as a domain on its own when defining domains of palliative care in dementia and drafting recommendations on how to care for dementia patients at the end of life. Continuity can be described as continuity of management (consistent and coherent management responsive to changing needs), information (use of information on past events and personal circumstances) and relations (ongoing therapeutic patient-provider(s) relationship). 1 Which of these three types, then, would be most important for people with dementia at the end of life? The first, continuity of management, is especially important in other chronic and complex diseases such as diabetes, and therefore may be important in dementia care. Mental health care is particularly well served by continuity of management coordinating health and social services, and relations with stable patient-team relationships (and perhaps a trusting relationship to discuss sensitive issues is important in dementia as well?). Continuity of information and relations may be particularly relevant in care at the end of life, including dementia at the end of life. Therefore, as dementia follows a chronic progressive trajectory, and involves decline in mental health, and is ultimately terminal, we may be unable to prioritise the three types of continuity for relevance at the end of life because all are equally highly important. The expert who raised the issue when evaluating our draft recommendations considered continuity of relations infeasible, even though this is what families and patients generally want, and therefore regarded continuity of information as the most important.
When drafting recommendations, however, we aspire to the best possible care, and therefore we aim to achieve continuity in all respects. This may touch upon a fundamental issue of why we need specific guidelines for dementia at the end of life. It is the complexity of managing a disease that is chronic, progressive, as well as life-threatening, which gives rise to multiple and varying needs; and involves the patient and the relatives. Palliative care, by its holistic nature, is to manage such complex situations, and providing palliative care to people with dementia may improve the recognition, address complex needs and ensure continuous high-quality care at the end of life or earlier.
In this issue of the journal, three articles 2-4 relate to professional caregivers' views on providing high-quality care for severely ill people with impaired cognition, people who cannot express themselves in a way we understand easily due to delirium 2 or dementia. 3, 4 The articles discuss several types of continuity of care.
Agar et al. 2 examined nurses' views on assessment and management of delirium in palliative settings. Nurses failed to acknowledge the importance of a change in cognition, in assessing delirium. Symptoms were miscommunicated or forgotten at inter-shift and physician-nurse handover.
Ryan et al. 3 addressed staff-perceived barriers to transition to palliative care in dementia. Staff advocated for greater emphasis being placed on planning ahead. Trusting relationships between all involved should be established, and this will not only help families and patients to make sensitive decisions such as around feeding but will also help staff in feeling confident in decision-making. Staff noted a tension with specialist palliative services coming in, who lacked this 'long view'. This may pose a dilemma, continuity of relationships being important, as well as access to specialist palliative care services. One solution is education and training of staff who have the continuous relationships, usually specialised in dementia care, to enable them to provide at least basic palliative care themselves. Research may compare such different models of care for providing highquality end-of-life care, and for its transportability.
Jordan et al. 4 studied two tools that may help assess, manage and evaluate pain (Pain Assessment in Advanced Dementia (PAINAD) Scale), and discomfort (Disability Distress Assessment Tool (DisDAT)) in people with dementia and communication difficulties. Their findings are important and promising; both tools are valuable as they increased the ability to identify pain or distress, to intervene, and to improve patient outcome. Their work also points to areas for further research. In addition to the two tools addressing different concepts, there is one more fundamental difference that precludes drawing firm conclusions about which tool may be helpful in which situation, and this relates to continuity of information. The DisDAT relies on documented behaviours that are specific to a patient, and therefore is completed multiple times by a caregiver who has intimate knowledge 459305P MJ26710.1177/0269216312459305Palliative Medicinevan der Steen Palliative Medicine 26 (7) of the patient. The authors suggest the scores accompany the patient when transferred to the hospital. The PAINAD does not use previous information and relies on direct observation, exclusively. The benefit of the DisDAT is that it uses more continuous information, and the benefit of the PAINAD is that it can be completed by staff who do not know the patient. Therefore, the tools may have different applications and usefulness, and both may promote continuity of information depending on the situation. More work needs to be done, for example, the classical scale for discomfort, the Discomfort Scale-Dementia of Alzheimer Type (DS-DAT). 5 which is in-between regarding these two fundamental differences, should be tested against these tools. Furthermore, proper instructions are important. The DS-DAT is not to be used when patients are disturbed by anything in the environment, and such instructions may avoid, in part, the misclassification of discomfort as pain, as identified by Jordan et al. Furthermore, the utility of highly specific items that are included in some well-known pain tools but not the PAINAD, such as guarding, should be examined for the ability to separate pain from discomfort due to other causes. Finally, a 2-min observation such as with the PAINAD cannot replace physical examination and proper diagnosis of pain. This is why more complex and stepwise interventions to identify and treat problems that may relate to pain or distress are appealing conceptually and practically. 6 Continuity of care is thus addressed in these three papers on care for people with impaired cognition. There is one other important commonality. Fundamental assumptions about under-recognition and under-treatment (of treatment to palliate) have prevailed over the last decades and underpin the three papers. However, recently, several countries documented a general increase in opioid use. In this context, it may be appropriate that Jordan et al. 4 warn that unjustified high pain scores (caused by, e.g. being disturbed by another patient) may result in overtreatment with analgesics, and Agar et al. 2 reported concerns on distress due to delirium attributed to pain treated with analgesics. On the other hand, there is a threat of under-treatment if symptoms are regarded as part of a 'normal' dying process. 2 Palliative care may play a role in seeking the right balance and proportionate treatment for individual patients.
Whether patients die from or with dementia, goals at the end of life are universal in people preferring a peaceful, dignified death, 2 which is free from pain and distress. 4 Further research on continuity of care in dementia and other patients with impaired cognition, and on which models and tools promote continuity and improve outcome may help ensure that the care for vulnerable people with impaired cognition including with dementia is of the best possible quality.
